Li, Ao <br/><br/>
The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.  [electronic resource] 

 -  European journal of pharmacology  Jan 2015 
 - 71-87 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2014.11.040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>14-3-3 Proteins--metabolism<br/>Active Transport, Cell Nucleus--drug effects<br/>Becaplermin<br/>Cell Line<br/>Cell Nucleus--drug effects<br/>Cell Proliferation--drug effects<br/>Cyclin D1--metabolism<br/>Cyclin-Dependent Kinase 4--metabolism<br/>Cyclin-Dependent Kinase 6--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p27--metabolism<br/>Down-Regulation--drug effects<br/>Forkhead Box Protein O3<br/>Forkhead Transcription Factors--deficiency<br/>Furans--pharmacology<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>Gene Expression Regulation, Enzymologic--drug effects<br/>Gene Knockdown Techniques<br/>Hepatic Stellate Cells--cytology<br/>Humans<br/>Lignans--pharmacology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Proto-Oncogene Proteins c-sis--pharmacology<br/>RNA, Small Interfering--genetics<br/>Resting Phase, Cell Cycle--drug effects<br/>Signal Transduction--drug effects